{
  "nctId": "NCT02426138",
  "briefTitle": "Community Servings: Food as Medicine for Diabetes",
  "officialTitle": "Community Servings: Food as Medicine for Diabetes",
  "protocolDocument": {
    "nctId": "NCT02426138",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2015-04-19",
    "uploadDate": "2019-04-14T10:14",
    "size": 339480,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT02426138/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "CROSSOVER",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 44,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2015-04-01",
    "completionDate": "2017-07-31",
    "primaryCompletionDate": "2017-07-31",
    "firstSubmitDate": "2015-03-07",
    "firstPostDate": "2015-04-24"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* • Diagnosis of type 2 diabetes\n\n  * Age 18 years or older\n  * HbA1c level \\>8.0%\n  * Report food insecurity as indicated by the 2-item USDA Food Security Survey Module13\n  * Willing to commit to random assignment to either receive CS meals immediately or as a waitlist control\n  * Stable health, with no severe medical comorbidities that might interfere with their ability to participate in the intervention, such as severe psychiatric illness or imminent hospitalization\n  * Be willing to keep a food diary\n  * Be willing to attend and complete a baseline, 12 week, and 24 week assessment at MGH\n  * Be able to understand and communicate effectively in English\n  * Have a primary care physician within the MGH practice based research network\n  * Live in an area where Community Servings can deliver meals\n  * Ability to store and prepare Community Servings meals\n\nExclusion Criteria:\n\n* • Must not be pregnant or planning pregnancy in the next year\n\n  * Currently enrolled in another diabetes study Food allergy that would prohibit consumption of meals\n  * Receiving episodic treatments that may increase blood glucose levels (e.g. prednisone)",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Healthy Eating Index 2010 Score",
        "description": "Calculated using data from ASA24 24-hour dietary recall tool Healthy Eating Index 2010 Score Minimum and Maximum range = 0 to 100 Higher scores indicate better diet quality The score is an average of the three-time periods that data was collected",
        "timeFrame": "Average of 3 24-hour food recalls per study period (on and off meals; one in-person visit and 2 over the phone at 4 and 8 weeks into the study)"
      }
    ],
    "secondary": [
      {
        "measure": "Number of Participants With Food Insecurity",
        "description": "Food insecurity is defined as \\> 2 affirmative responses on the 10 adult referenced items USDA Household Food Security Survey Module",
        "timeFrame": "Measured at end of On-Meals Period and end of Off-Meals Period for each participant"
      },
      {
        "measure": "Diabetes Distress Scale",
        "description": "Diabetes Distress calculated using the Diabetes Distress Scale Minimum and Maximum scores range of the scale is 17-106 For this measure the lower the score the better",
        "timeFrame": "Measured at end of On-Meals Period and end of Off-Meals Period for each participant"
      }
    ],
    "other": [
      {
        "measure": "Hemoglobin A1c",
        "description": "This will be measured using a fasting blood draw at baseline, 12 and 24 weeks",
        "timeFrame": "Measured at end of On-Meals Period and end of Off-Meals Period for each participant"
      },
      {
        "measure": "LDL Cholesterol",
        "description": "A fasting blood draw will be used to measure: LDL Cholesterol",
        "timeFrame": "Measured at end of On-Meals Period and end of Off-Meals Period for each participant"
      },
      {
        "measure": "Body Mass Index",
        "description": "Body Mass Index will be measured in light street clothes (without shoes) using a single calibrated scale.\n\nHeight measured using a stadiometer. Body Mass Index (BMI) is a person's weight in kilograms divided by the square of height in meters.\n\nA high BMI can be an indicator of high body fatness.",
        "timeFrame": "Measured at end of On-Meals Period and end of Off-Meals Period for each participant"
      },
      {
        "measure": "Systolic Blood Pressure",
        "description": "Measured using a calibrated sphygmomanometer with appropriate cuff sizes based on arm circumference. Average of 2 readings, first manual and second automated at 1 min intervals following a 5 min period of rest.",
        "timeFrame": "Measured at end of On-Meals Period and end of Off-Meals Period for each participant using a calibrated sphygmomanometer"
      },
      {
        "measure": "Diastolic Blood Pressure",
        "description": "Measured using a calibrated sphygmomanometer with appropriate cuff sizes based on arm circumference. Average of 2 readings, first manual and second automated at 1 min intervals following a 5 min period of rest.",
        "timeFrame": "Measured at end of On-Meals Period and end of Off-Meals Period for each participant using a calibrated sphygmomanometer"
      },
      {
        "measure": "Change From Baseline in Medication Adherence",
        "description": "Change from baseline in Medication Adherence Rating Scale (Assessed using medication adherence rating scale) Range is 0-25 The higher the number the better",
        "timeFrame": "Measured at end of On-Meals Period and end of Off-Meals Period for each participant"
      },
      {
        "measure": "Number of Participants With Cost Related Medication Under-Use",
        "description": "Cost Related Medication Under-use (Defined as \\> 0 affirmative responses to 4-items on cost-related medication under-use from the medication expenditure panel survey)",
        "timeFrame": "Measured at end of On-Meals Period and end of Off-Meals Period for each participant"
      },
      {
        "measure": "Number of Participants With Food and Medication Trade-offs",
        "description": "Prevalence of food and medication trade-offs between groups",
        "timeFrame": "Measured at end of On-Meals Period and end of Off-Meals Period for each participant"
      },
      {
        "measure": "Depressive Symptoms (Assessed Using the PHQ-8 Scale)",
        "description": "Patient Health Questionnaire - 8 item version. The score ranges 0-24, The lower score represents less depressive symptoms",
        "timeFrame": "Measured at end of On-Meals Period and end of Off-Meals Period for each participant"
      },
      {
        "measure": "Change From Baseline in Cognitive Burden (Assessed Using Times on the Stroop Task)",
        "description": "This outcome was planned to be measured but not measured owing to technical difficulties in assessment",
        "timeFrame": "Measured at end of On-Meals Period and end of Off-Meals Period for each participant"
      },
      {
        "measure": "Number of Participants With Self-reported Hypoglycemia",
        "description": "Report of hypoglycemia requiring assistance in last 3 months",
        "timeFrame": "Measured at end of On-Meals Period and end of Off-Meals Period for each participant"
      },
      {
        "measure": "Triglycerides",
        "description": "A fasting blood draw will be used to measure: Triglycerides",
        "timeFrame": "Measured at end of On-Meals Period and end of Off-Meals Period for each participant by fasting blood draw"
      },
      {
        "measure": "HDL Cholesterol",
        "description": "A fasting blood draw will be used to measure: HDL Cholesterol",
        "timeFrame": "Measured at end of On-Meals Period and end of Off-Meals Period for each participant by fasting blood draw"
      },
      {
        "measure": "Total Cholesterol",
        "description": "A fasting blood draw will be used to measure: Total Cholesterol",
        "timeFrame": "Measured at end of On-Meals Period and end of Off-Meals Period for each participant by fasting blood draw"
      }
    ]
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 2,
      "otherCount": 14,
      "totalCount": 17
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": false,
      "interventionModel": "CROSSOVER"
    },
    "overallComplexityScore": 62,
    "complexityCategory": "Complex"
  },
  "collectionDate": "2025-09-22T02:29:09.422Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}